AJG - Arthur J. Gallagher & Co.

📈 Recent Price Action

AJG shares closed at $224.46, up 0.62% on the day and 2.07% over the past week. The stock has gained 4.49% over the last month, recovering from its YTD decline of 13.27%. The RSI of 56.69 suggests neither overbought nor oversold conditions.

🎯 Short Interest Analysis

Short interest remains very low at 2.85% of free float, with 5.83M shares short as of March 31, 2026. This represents a 6.68% increase week-over-week and 1.96% month-over-month, indicating slight upticks in bearish positioning.

Key Short Metrics:

• Days to Cover: 4.57 (up from 2.64 on March 31)
• Cost to Borrow: 0.23% APR — dropped 53.9% in the past week from 0.46%, suggesting reduced demand for short positions
• Availability: 1,908% of SI — extremely high, making shares very easy to borrow
• Utilization: 5.03% — very low, indicating minimal stress on the borrow market

The combination of low short interest, dirt-cheap borrowing costs, and minimal utilization suggests short sellers have little conviction in AJG's downside.

📉 Options Sentiment

The put/call ratio of 0.431 is below the 20-day average of 0.49, signaling bullish options positioning. The PCR has a z-score of -1.97, indicating significantly more call buying than usual. This suggests traders are positioning for upside.

🏆 ORTEX Stock Scores (as of April 22)

AJG's growth score of 64.11 is its standout strength, reflecting solid fundamental expansion. However, value (32.84) and momentum (35.19) scores lag, suggesting the stock isn't cheap and lacks strong near-term price momentum despite recent gains.

📅 Upcoming Catalyst

Next Earnings: April 30, 2026 at 4:00 PM ET — Q1 2026 results

Analyst return potential stands at 20.92%, indicating Wall Street sees upside from current levels. The dividend yield is 1.25%.

💡 Bottom Line

AJG shows low short interest and bullish options sentiment, with shares rebounding modestly after a YTD decline. The stock's strength lies in growth fundamentals, though valuation and momentum metrics are less compelling. With minimal short pressure and earnings on the horizon, the setup is neutral-to-bullish for patient investors.

This is not financial advice. Always do your own research.